Profile
Kristina Cutter is currently Chief Development Officer at Alector, Inc. since 2019.
Former positions include Head-Global Regulatory at Genentech, Inc. and Vice President-Regulatory & Safety at Halozyme Therapeutics, Inc. Education includes graduate studies at the University of Michigan School of Public Health.
Kristina Cutter active positions
| Companies | Position | Start |
|---|---|---|
| ALECTOR, INC. | Corporate Officer/Principal | - |
Former positions of Kristina Cutter
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Kristina Cutter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
University of Michigan School of Public Health
University of Michigan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Kristina Cutter
















